5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid

C123H81F3N28O15S6 — CID 161064902

IUPAC5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid
SMILESC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC.CN(C)Cc1ccc(-c2cnn(C3=CC(=O)NS3=O)c2)cc1.CN(C)Cc1cccc(-c2cnn(C3=CC(=O)NS3=O)c2)c1.CN1CCN(c2cc(-c3cnn(C4=CC(=O)NS4=O)c3)ccn2)CC1.COc1cc(-c2cnn(C3=CC(=O)NS3=O)c2)ccn1.O=C(O)C(F)(F)F.O=C1C=C(n2cc(-c3cnc4ccccc4n3)cn2)S(=O)N1.O=C1C=C(n2cc(-c3cnccn3)cn2)S(=O)N1
InChIInChI=1S/C39H4.C16H18N6O2S.2C15H16N4O2S.C14H9N5O2S.C12H10N4O3S.C10H7N5O2S.C2HF3O2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;1-20-4-6-21(7-5-20)14-8-12(2-3-17-14)13-10-18-22(11-13)16-9-15(23)19-25(16)24;1-18(2)9-11-3-5-12(6-4-11)13-8-16-19(10-13)15-7-14(20)17-22(15)21;1-18(2)9-11-4-3-5-12(6-11)13-8-16-19(10-13)15-7-14(20)17-22(15)21;20-13-5-14(22(21)18-13)19-8-9(6-16-19)12-7-15-10-3-1-2-4-11(10)17-12;1-19-11-4-8(2-3-13-11)9-6-14-16(7-9)12-5-10(17)15-20(12)18;16-9-3-10(18(17)14-9)15-6-7(4-13-15)8-5-11-1-2-12-8;3-2(4,5)1(6)7/h1H,2H3;2-3,8-11H,4-7H2,1H3,(H,19,23);2*3-8,10H,9H2,1-2H3,(H,17,20);1-8H,(H,18,20);2-7H,1H3,(H,15,17);1-6H,(H,14,16);(H,6,7)
InChIKeyIAGGCJPXVQKYCS-UHFFFAOYSA-N
MW2440.58 g/mol
LogP5.59
Rot. Bonds18

About 5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid

5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid (PubChem CID 161064902) has the molecular formula C123H81F3N28O15S6 and a molecular weight of 2440.58 g/mol. Its IUPAC name is 5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid.

Molecular Properties

Compound Name5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid
PubChem CID161064902
Molecular FormulaC123H81F3N28O15S6
Molecular Weight2440.58 g/mol
Exact Mass2438.47
IUPAC Name5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid
SMILESC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC.CN(C)Cc1ccc(-c2cnn(C3=CC(=O)NS3=O)c2)cc1.CN(C)Cc1cccc(-c2cnn(C3=CC(=O)NS3=O)c2)c1.CN1CCN(c2cc(-c3cnn(C4=CC(=O)NS4=O)c3)ccn2)CC1.COc1cc(-c2cnn(C3=CC(=O)NS3=O)c2)ccn1.O=C(O)C(F)(F)F.O=C1C=C(n2cc(-c3cnc4ccccc4n3)cn2)S(=O)N1.O=C1C=C(n2cc(-c3cnccn3)cn2)S(=O)N1
InChIInChI=1S/C39H4.C16H18N6O2S.2C15H16N4O2S.C14H9N5O2S.C12H10N4O3S.C10H7N5O2S.C2HF3O2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;1-20-4-6-21(7-5-20)14-8-12(2-3-17-14)13-10-18-22(11-13)16-9-15(23)19-25(16)24;1-18(2)9-11-3-5-12(6-4-11)13-8-16-19(10-13)15-7-14(20)17-22(15)21;1-18(2)9-11-4-3-5-12(6-11)13-8-16-19(10-13)15-7-14(20)17-22(15)21;20-13-5-14(22(21)18-13)19-8-9(6-16-19)12-7-15-10-3-1-2-4-11(10)17-12;1-19-11-4-8(2-3-13-11)9-6-14-16(7-9)12-5-10(17)15-20(12)18;16-9-3-10(18(17)14-9)15-6-7(4-13-15)8-5-11-1-2-12-8;3-2(4,5)1(6)7/h1H,2H3;2-3,8-11H,4-7H2,1H3,(H,19,23);2*3-8,10H,9H2,1-2H3,(H,17,20);1-8H,(H,18,20);2-7H,1H3,(H,15,17);1-6H,(H,14,16);(H,6,7)
InChIKeyIAGGCJPXVQKYCS-UHFFFAOYSA-N
XLogP5.59
TPSA520.77 Ų
H-Bond Donors7
H-Bond Acceptors36
Rotatable Bonds18
Heavy Atoms175
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002440.58
LogP ≤ 55.59
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1036

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid?
The IUPAC name of 5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid (CID 161064902) is 5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid.
What is the SMILES notation for 5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid?
The canonical SMILES for 5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid is C#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC.CN(C)Cc1ccc(-c2cnn(C3=CC(=O)NS3=O)c2)cc1.CN(C)Cc1cccc(-c2cnn(C3=CC(=O)NS3=O)c2)c1.CN1CCN(c2cc(-c3cnn(C4=CC(=O)NS4=O)c3)ccn2)CC1.COc1cc(-c2cnn(C3=CC(=O)NS3=O)c2)ccn1.O=C(O)C(F)(F)F.O=C1C=C(n2cc(-c3cnc4ccccc4n3)cn2)S(=O)N1.O=C1C=C(n2cc(-c3cnccn3)cn2)S(=O)N1.
What is the InChIKey of 5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid?
The InChIKey is IAGGCJPXVQKYCS-UHFFFAOYSA-N. The full InChI is InChI=1S/C39H4.C16H18N6O2S.2C15H16N4O2S.C14H9N5O2S.C12H10N4O3S.C10H7N5O2S.C2HF3O2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;1-20-4-6-21(7-5-20)14-8-12(2-3-17-14)13-10-18-22(11-13)16-9-15(23)19-25(16)24;1-18(2)9-11-3-5-12(6-4-11)13-8-16-19(10-13)15-7-14(20)17-22(15)21;1-18(2)9-11-4-3-5-12(6-11)13-8-16-19(10-13)15-7-14(20)17-22(15)21;20-13-5-14(22(21)18-13)19-8-9(6-16-19)12-7-15-10-3-1-2-4-11(10)17-12;1-19-11-4-8(2-3-13-11)9-6-14-16(7-9)12-5-10(17)15-20(12)18;16-9-3-10(18(17)14-9)15-6-7(4-13-15)8-5-11-1-2-12-8;3-2(4,5)1(6)7/h1H,2H3;2-3,8-11H,4-7H2,1H3,(H,19,23);2*3-8,10H,9H2,1-2H3,(H,17,20);1-8H,(H,18,20);2-7H,1H3,(H,15,17);1-6H,(H,14,16);(H,6,7).
What are the key properties of 5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid?
5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid has a molecular weight of 2440.58 g/mol, XLogP of 5.59, 18 rotatable bonds, 7 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[4-[3-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[4-[(dimethylamino)methyl]phenyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(2-methoxy-4-pyridinyl)pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]pyrazol-1-yl]-1-oxo-1,2-thiazol-3-one;nonatriaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37-nonadecayne;1-oxo-5-(4-pyrazin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-(4-quinoxalin-2-ylpyrazol-1-yl)-1,2-thiazol-3-one;2,2,2-trifluoroacetic acid is sourced from PubChem (CID 161064902), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).